Amir Valizadeh

559 total citations
30 papers, 386 citations indexed

About

Amir Valizadeh is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Amir Valizadeh has authored 30 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Physiology. Recurrent topics in Amir Valizadeh's work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (3 papers) and Endometriosis Research and Treatment (3 papers). Amir Valizadeh is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (3 papers) and Endometriosis Research and Treatment (3 papers). Amir Valizadeh collaborates with scholars based in Iran, United States and China. Amir Valizadeh's co-authors include Mehdi Yousefi, Bahman Yousefi, Samira Asghari, Mohammad Nouri, Leili Aghebati‐Maleki, Maryam Majidinia, Hossein Samadi Kafil, Zatollah Asemi, Ansar Karimian and Seyed Mostafa Mir and has published in prestigious journals such as Biochemical Pharmacology, European Journal of Pharmacology and Journal of Cellular Physiology.

In The Last Decade

Amir Valizadeh

29 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amir Valizadeh Iran 10 150 81 81 79 55 30 386
Youguo Chen China 16 301 2.0× 89 1.1× 184 2.3× 100 1.3× 44 0.8× 41 665
Shihong Shao China 12 86 0.6× 64 0.8× 36 0.4× 25 0.3× 27 0.5× 27 368
Xiaofen Yao China 9 282 1.9× 130 1.6× 116 1.4× 126 1.6× 148 2.7× 10 633
Jianming Huang China 13 211 1.4× 90 1.1× 128 1.6× 55 0.7× 54 1.0× 41 450
Junrong Wu China 10 107 0.7× 38 0.5× 52 0.6× 27 0.3× 35 0.6× 20 384
Elaine Rufo Tavares Brazil 13 102 0.7× 84 1.0× 79 1.0× 35 0.4× 100 1.8× 25 384
Xiaohua Wu China 3 174 1.2× 35 0.4× 133 1.6× 53 0.7× 66 1.2× 3 407
Wen‐Chih Huang Taiwan 12 146 1.0× 22 0.3× 45 0.6× 66 0.8× 101 1.8× 33 429
Zhu Yang China 17 519 3.5× 190 2.3× 263 3.2× 107 1.4× 42 0.8× 36 860
Rui Zhong China 13 236 1.6× 43 0.5× 136 1.7× 14 0.2× 72 1.3× 37 491

Countries citing papers authored by Amir Valizadeh

Since Specialization
Citations

This map shows the geographic impact of Amir Valizadeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Valizadeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Valizadeh more than expected).

Fields of papers citing papers by Amir Valizadeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amir Valizadeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Valizadeh. The network helps show where Amir Valizadeh may publish in the future.

Co-authorship network of co-authors of Amir Valizadeh

This figure shows the co-authorship network connecting the top 25 collaborators of Amir Valizadeh. A scholar is included among the top collaborators of Amir Valizadeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir Valizadeh. Amir Valizadeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valizadeh, Amir, et al.. (2025). Ferroptosis and immunotherapy: Breaking barriers in cancer treatment resistance. Critical Reviews in Oncology/Hematology. 214. 104907–104907. 3 indexed citations
2.
Valizadeh, Amir, et al.. (2024). Thymoquinone reversed doxorubicin resistance in U87 glioblastoma cells via targeting PI3K/Akt/mTOR signaling. Chemical Biology & Drug Design. 104(2). e14587–e14587. 1 indexed citations
3.
Valizadeh, Amir, et al.. (2024). Targeted therapy of gastric cancer with gingerol-loaded hyaluronic acid/PEG-coated PLGA nanoparticles: Development and physicochemical evaluation. Journal of Drug Delivery Science and Technology. 97. 105734–105734. 12 indexed citations
4.
5.
Yousefi, Bahman, et al.. (2024). Thymoquinone Increases the Sensitivity of SW‐480 Colon Cancer Cells to 5‐Fluorouracil. BioMed Research International. 2024(1). 6231095–6231095. 4 indexed citations
6.
Zarezadeh, Reza, Amir Valizadeh, Amir Mehdizadeh, et al.. (2023). White-brown adipose tissue interplay in polycystic ovary syndrome: Therapeutic avenues. Biochemical Pharmacology. 220. 116012–116012. 6 indexed citations
7.
Yazdani, Yalda, Arezoo Rezaie Nezhad Zamani, Shaban Alizadeh, et al.. (2023). Curcumin and targeting of molecular and metabolic pathways in multiple sclerosis. Cell Biochemistry and Function. 41(7). 779–787. 8 indexed citations
8.
Valizadeh, Amir, Ali Abedelahi, Hajar Shafaei, et al.. (2023). Strategies for modifying the chimeric antigen receptor (CAR) to improve safety and reduce toxicity in CAR T cell therapy for cancer. International Immunopharmacology. 125(Pt A). 111093–111093. 5 indexed citations
9.
10.
Safaie, Naser, Amir Valizadeh, Masoud Pezeshkian, et al.. (2021). The serum levels of testosterone in coronary artery disease patients; relation to NO, eNOS, endothelin-1, and disease severity. Hormone Molecular Biology and Clinical Investigation. 43(1). 55–61. 6 indexed citations
11.
Targhazeh, Niloufar, et al.. (2021). MiR‐622 acts as a tumor suppressor to induce cell apoptosis and inhibit metastasis in human prostate cancer. Andrologia. 53(9). e14174–e14174. 9 indexed citations
12.
Valizadeh, Amir, et al.. (2021). Regulatory Roles of the Notch Signaling Pathway in Liver Repair andRegeneration: A Novel Therapeutic Target. Current Medicinal Chemistry. 28(41). 8608–8626. 7 indexed citations
13.
Valizadeh, Amir, Samira Asghari, Forough Alemi, et al.. (2021). The Roles of Signaling Pathways in Cardiac Regeneration. Current Medicinal Chemistry. 29(12). 2142–2166. 5 indexed citations
14.
Asghari, Samira, Mohammad Nouri, Masoud Darabi, & Amir Valizadeh. (2020). Steroid‐depleted endometriosis serum improves oocyte maturation in IVM systems. Journal of Cellular Physiology. 236(1). 205–214. 2 indexed citations
15.
Valizadeh, Amir, et al.. (2020). miR-192 enhances sensitivity of methotrexate drug to MG-63 osteosarcoma cancer cells. Pathology - Research and Practice. 216(11). 153176–153176. 28 indexed citations
16.
Valizadeh, Amir, et al.. (2020). miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells. European Journal of Pharmacology. 880. 173138–173138. 47 indexed citations
17.
Mirza‐Aghazadeh‐Attari, Mohammad, Shahin Hallaj, Amir Ata Saei, et al.. (2019). Crosstalk between P53 and DNA damage response in ageing. DNA repair. 80. 8–15. 23 indexed citations
18.
Asghari, Samira, Amir Valizadeh, Leili Aghebati‐Maleki, Mohammad Nouri, & Mehdi Yousefi. (2018). Endometriosis: Perspective, lights, and shadows of etiology. Biomedicine & Pharmacotherapy. 106. 163–174. 75 indexed citations
19.
Asghari, Samira, Amir Valizadeh, Majid Ahmadi, et al.. (2018). Evaluation of ovarian cancer risk in granulosa cells treated with steroid‐depleted endometriosis serum: Role of NF‐κB/RelA and AKT. Journal of Cellular Physiology. 234(7). 12011–12018. 8 indexed citations
20.
Valizadeh, Amir, et al.. (2016). Effect of Dexamethasone on Glycocalyx Injury and Endothelin (ET)-B Receptor Gene Expression in Liver Tissue during Hepatic Warm Ischemia/Reperfusion in Rats. Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences. 25(134). 20–32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youguo Chen Breakdown of academic impact, for papers by Shihong Shao Breakdown of academic impact, for papers by Xiaofen Yao Breakdown of academic impact, for papers by Jianming Huang Breakdown of academic impact, for papers by Junrong Wu Breakdown of academic impact, for papers by Elaine Rufo Tavares Breakdown of academic impact, for papers by Xiaohua Wu Breakdown of academic impact, for papers by Wen‐Chih Huang Breakdown of academic impact, for papers by Zhu Yang Breakdown of academic impact, for papers by Rui Zhong
Rankless by CCL
2026